Literature DB >> 24126704

miR-21 is a critical therapeutic target for renal fibrosis.

Yong He1, Cheng Huang, Jun Li.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24126704     DOI: 10.1007/s12013-013-9745-y

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


× No keyword cloud information.
  5 in total

1.  miR-21 Inhibition Reduces Liver Fibrosis and Prevents Tumor Development by Inducing Apoptosis of CD24+ Progenitor Cells.

Authors:  Jing Zhang; Jingjing Jiao; Silvia Cermelli; Kyle Muir; Kwang Hwa Jung; Ruhai Zou; Asif Rashid; Mihai Gagea; Sonya Zabludoff; Raghu Kalluri; Laura Beretta
Journal:  Cancer Res       Date:  2015-03-13       Impact factor: 12.701

Review 2.  Potential application of miRNAs as diagnostic and therapeutic tools in chronic pancreatitis.

Authors:  Liang-Hao Hu; Jun-Tao Ji; Zhao-Shen Li
Journal:  J Cell Mol Med       Date:  2015-07-06       Impact factor: 5.310

3.  Radix puerariae extracts ameliorate paraquat-induced pulmonary fibrosis by attenuating follistatin-like 1 and nuclear factor erythroid 2p45-related factor-2 signalling pathways through downregulation of miRNA-21 expression.

Authors:  Ming-Wei Liu; Rong Liu; Hai-Ying Wu; Yi-Yun Li; Mei-Xian Su; Min-Na Dong; Wei Zhang; Chuan-Yun Qian
Journal:  BMC Complement Altern Med       Date:  2016-01-12       Impact factor: 3.659

4.  MicroRNA-21-containing microvesicles from tubular epithelial cells promote cardiomyocyte hypertrophy.

Authors:  Jia Di; Min Yang; Hua Zhou; Min Li; Jiabi Zhao
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

5.  MiR542-3p Regulates the Epithelial-Mesenchymal Transition by Directly Targeting BMP7 in NRK52e.

Authors:  Zhicheng Liu; Yuru Zhou; Yue Yuan; Fang Nie; Rui Peng; Qianyin Li; Zhongshi Lyu; Zhaomin Mao; Liyuan Huang; Li Zhou; Yiman Li; Jing Hao; Dongsheng Ni; Qianni Jin; Yaoshui Long; Pan Ju; Wen Yu; Jianing Liu; Yanxia Hu; Qin Zhou
Journal:  Int J Mol Sci       Date:  2015-11-24       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.